Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
969.49%
operating margin TTM
-895.47%
revenue TTM
13.88 Thousand
revenue per share TTM
0.02$
valuation ratios | |
|---|---|
| pe ratio | 0.92 |
| peg ratio | 0.02 |
| price to book ratio | 0.45 |
| price to sales ratio | 9.00 |
| enterprise value multiple | -1.31 |
| price fair value | 0.45 |
profitability ratios | |
|---|---|
| gross profit margin | -177.37% |
| operating profit margin | -895.47% |
| pretax profit margin | -1179.67% |
| net profit margin | 969.49% |
| return on assets | 44.42% |
| return on equity | 92.06% |
| return on capital employed | -44.25% |
liquidity ratio | |
|---|---|
| current ratio | 4.59 |
| quick ratio | 4.59 |
| cash ratio | 3.77 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 338.18 |
| days of payables outstanding | 76.90 |
| cash conversion cycle | 261.28 |
| receivables turnover | 1.08 |
| payables turnover | 4.75 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | -479.22 |
| cash flow to debt ratio | -136.44 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.06 |
| cash per share | 0.03 |
| operating cash flow per share | -0.06 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -136.44 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -2,409.91 |
Frequently Asked Questions
When was the last time Addex Therapeutics Ltd (NASDAQ:ADXN) reported earnings?
Addex Therapeutics Ltd (ADXN) published its most recent earnings results on 22-11-2024.
What is Addex Therapeutics Ltd's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Addex Therapeutics Ltd (NASDAQ:ADXN)'s trailing twelve months ROE is 92.06%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Addex Therapeutics Ltd (ADXN) currently has a ROA of 44.42%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ADXN's net profit margin stand at?
ADXN reported a profit margin of 969.49% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ADXN's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.59 in the most recent quarter. The quick ratio stood at 4.59, with a Debt/Eq ratio of 0.00.